Clinical Trial

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

Name: Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage — clinical trial record (NCT07053852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

To provide a treatment of both actinic keratoses and photodamage within one treatment.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-06-26; most recent amendment 2025-12-29.

Status change: Recruiting → Completed 2025-12-29

Trial Details

NCT Number	NCT07053852
Lead Sponsor	Sherrif Ibrahim Collaborators: Sciton, Biofrontera Bioscience GmbH
Conditions	Actinic Keratoses, Photodamage
Enrollment	10 participants
Start Date	2025-06-27
Primary Completion	2025-12-29 (estimated)
Study Completion	2025-12-29 (estimated)
Updated on ClinicalTrials.gov	2026-01-02